Numerous first generation phosphorothioates (PS) and their derivatives have shown promise targeting mRNA for therapeutic applications and also gained market approval for their use as a drug. However, PS have n...
from Most Recent Articles: Journal of Nanobiotechnology http://bit.ly/2IQVFx9
via IFTTT
No comments:
Post a Comment